Corient Private Wealth
SBRA icon

Corient Private Wealth’s Sabra Healthcare REIT SBRA Stock Holding History

Corient Private Wealth’s Portfolio SBRA Stock Details SBRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.41M Sell
123,648
-5,277
-4% -$105K ﹤0.01% 1273
2026
Q1 		$2.48M Buy
128,925
+114,876
+818% +$2.26M ﹤0.01% 1155
2025
Q4 		$266K Buy
+14,049
New +$260K ﹤0.01% 2249
2025
Q1 		– Sell
-13,860
Closed -$240K – 2426
2024
Q4 		$240K Sell
13,860
-3,940
-22% -$71.9K ﹤0.01% 2015
2024
Q3 		$331K Sell
17,800
-2,238
-11% -$37.7K ﹤0.01% 1969
2024
Q2 		$309K Sell
20,038
-12,406
-38% -$177K ﹤0.01% 1888
2024
Q1 		$479K Buy
32,444
+424
+1% +$5.87K ﹤0.01% 1648
2023
Q4 		$457K Buy
32,020
+475
+2% +$6.75K ﹤0.01% 1656
2023
Q3 		$440K Buy
31,545
+18,061
+134% +$231K ﹤0.01% 1566
2023
Q2 		$159K Buy
13,484
+412
+3% +$4.69K ﹤0.01% 1917
2023
Q1 		$150K Buy
+13,072
New +$162K ﹤0.01% 1837

Other funds holding SBRA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CIM
Centersquare Investment Management Conshohocken, Pennsylvania $11.7B AUM 20.39% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Corient Private Wealth's SBRA Position: Q2 2026 in Review

Corient Private Wealth reduced its Sabra Healthcare REIT (SBRA) stake by 4.1% in Q2 2026, selling an estimated $105K and leaving 123,648 shares worth $2.41M. The position accounts for ﹤0.01% of the portfolio, ranked #1273.

Corient Private Wealth first reported a position in SBRA in Q1 2023 and has held it in 11 quarters since. The position peaked at $2.48M in Q1 2026. 464 funds tracked by Wall St. Rank hold SBRA as of Q2 2026.

  • Corient Private Wealth held 123,648 shares of Sabra Healthcare REIT worth $2.41M as of Q2 2026.
  • Corient Private Wealth sold 5,277 Sabra Healthcare REIT shares in Q2 2026, an estimated $105K.
  • Sabra Healthcare REIT made up ﹤0.01% of Corient Private Wealth's portfolio in Q2 2026, its #1273 holding.
  • Corient Private Wealth first reported a position in Sabra Healthcare REIT in Q1 2023 and has held it in 11 quarters since.
  • Corient Private Wealth's Sabra Healthcare REIT position peaked at $2.48M in Q1 2026.
  • 464 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q2 2026.

Based on Corient Private Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.